Drugs / intramyocardial injection (electromechanical mapping based)
intramyocardial injection (electromechanical mapping based)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01660581 | Jun 2012 → Sep 2016 | coronary artery disorder | Medical University of Silesia | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | intramyocardial injection (electromechanical mapping based) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01660581 ↗ |
| Modality | Cell therapy | “The purpose of the study is to evaluate the efficacy of therapy with autological CD133+ cells in patients with angina resistant to pharmacological treatment” NCT01660581 ↗ |
| Route | Other | “administered directly into the muscle of left ventricle” NCT01660581 ↗ |